Friis Lorna M, Keelan Monika, Taylor Diane E
Department of Medical Microbiology and Immunology, University of Alberta, 1-63 Medical Sciences Building, Edmonton T6G 2H7, Alberta, Canada.
Infect Immun. 2009 Apr;77(4):1553-60. doi: 10.1128/IAI.00707-08. Epub 2009 Jan 12.
Gastrointestinal disease caused by Campylobacter jejuni is characterized by localized inflammation and the destruction of the epithelial cell barrier that forms host innate protection against pathogens. This can lead to an imbalance in fluid transport across the gastrointestinal tract, resulting in severe diarrhea. The mechanisms of host cell receptor recognition of C. jejuni and downstream immune signaling pathways leading to this inflammatory disease, however, remain unclear. The aim of this study was to analyze the mechanisms involved in C. jejuni induction of the acute-phase inflammatory response regulator interleukin-6 (IL-6). Polarized intestinal epithelial Caco-2 monolayers responded to infections with Salmonella enterica serovar Typhimurium and eight isolates of C. jejuni by an increase in levels of expression and secretion of IL-6. No such IL-6 response, however, was produced upon infection with the human commensal organism Lactobacillus rhamnosus GG. The IL-6 signaling pathway was further characterized using short interfering RNA complexes to block gene expression. The inhibition of myeloid differentiation primary response protein 88 (MyD88) expression in this manner did not affect C. jejuni-induced IL-6 secretion, suggesting a MyD88-independent route to IL-6 signal transduction in C. jejuni-infected human epithelial cells. However, a significant reduction in levels of IL-6 was evident in the absence of Toll-like receptor 2 (TLR-2) expression, implying a requirement for TLR-2 in C. jejuni recognition. Caco-2 cells were also treated with heat-inactivated and purified membrane components of C. jejuni to isolate the factor responsible for triggering IL-6 signaling. The results demonstrate that C. jejuni surface polysaccharides induce IL-6 secretion from intestinal epithelial cells via TLR-2 in a MyD88-independent manner.
空肠弯曲菌引起的胃肠道疾病的特征是局部炎症以及形成宿主抵御病原体天然保护屏障的上皮细胞屏障遭到破坏。这会导致胃肠道液体运输失衡,从而引发严重腹泻。然而,空肠弯曲菌的宿主细胞受体识别机制以及导致这种炎症性疾病的下游免疫信号通路仍不清楚。本研究的目的是分析空肠弯曲菌诱导急性期炎症反应调节因子白细胞介素-6(IL-6)的相关机制。极化的肠道上皮Caco-2单层细胞对鼠伤寒沙门氏菌和八株空肠弯曲菌的感染会通过增加IL-6的表达水平和分泌量做出反应。然而,用人类共生菌鼠李糖乳杆菌GG感染时却不会产生这种IL-6反应。使用小干扰RNA复合物阻断基因表达对IL-6信号通路进行了进一步表征。以这种方式抑制髓样分化初级反应蛋白88(MyD88)的表达并不影响空肠弯曲菌诱导的IL-6分泌,这表明在空肠弯曲菌感染的人类上皮细胞中,IL-6信号转导存在一条不依赖MyD88的途径。然而,在缺乏Toll样受体2(TLR-2)表达的情况下,IL-6水平显著降低,这意味着空肠弯曲菌识别需要TLR-2。还用热灭活和纯化的空肠弯曲菌膜成分处理Caco-2细胞,以分离负责触发IL-6信号的因子。结果表明,空肠弯曲菌表面多糖通过TLR-2以不依赖MyD88的方式诱导肠道上皮细胞分泌IL-6。